Neuroprotective Effects of Dibornol in Focal Cerebral Ischemia/Reperfusion in Rats. 2018

G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

Neuroprotective activity of 2,6-diisobornyl-4-methylphenol (Dibornol) was studied under conditions of experimental focal cerebral ischemia/reperfusion modeled by intraluminal occlusion of the left middle cerebral artery for 1 h followed by recirculation. Dibornol administered in a dose of 10 mg/kg intragastrically 24 h and 30 min before and 24 h after focal ischemia/reperfusion modeling reduced the size of the brain infarction zone by 52% (48 h after recirculation) and neurological deficit by 1.7-2.4 times in comparison with that in control animals.

UI MeSH Term Description Entries
D008297 Male Males
D001892 Camphanes Crystalline saturated MONOTERPENES, precursors of borneols and CAMPHENE. Bornanes,Bornenes,Fenchanes
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D003408 Cresols Any of three isomeric crystalline aromatic methylphenols, also known as hydroxytoluenes.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
October 2007, The Chinese journal of physiology,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2017, Neuropsychiatric disease and treatment,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
May 2014, Brain research,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
April 2019, International journal of molecular medicine,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
June 2008, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2012, Turkish neurosurgery,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2014, Journal of pharmacological sciences,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2015, Neural regeneration research,
G A Chenysheva, and V A Smol'akova, and A V Kutchin, and I Yu Chukicheva, and M B Plotnikov
January 2012, Journal of neurosurgical anesthesiology,
Copied contents to your clipboard!